M.E. Allison & Co’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$989K Sell
6,803
-400
-6% -$55.3K 0.55% 48
2026
Q2
$926K Buy
7,203
+59
+0.8% +$6.91K 0.53% 52
2026
Q1
$859K Sell
7,144
-499
-7% -$57.6K 0.57% 49
2025
Q4
$805K Hold
7,643
– – 0.55% 51
2025
Q3
$641K Buy
7,643
+500
+7% +$41.2K 0.45% 59
2025
Q2
$565K Buy
7,143
+694
+11% +$55.2K 0.45% 61
2025
Q1
$579K Buy
6,449
+1,001
+18% +$93.5K 0.57% 51
2024
Q4
$542K Buy
+5,448
New +$562K 0.6% 45

Other funds holding MRK

M.E. Allison & Co's MRK Position: Q3 2026 in Review

M.E. Allison & Co reduced its Merck (MRK) stake by 5.6% in Q3 2026, selling an estimated $55.3K and leaving 6,803 shares worth $989K. The position accounts for 0.55% of the portfolio, ranked #48.

M.E. Allison & Co first reported a position in MRK in Q4 2024 and has held it in 8 quarters since. 985 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • M.E. Allison & Co held 6,803 shares of Merck worth $989K as of Q3 2026.
  • M.E. Allison & Co sold 400 Merck shares in Q3 2026, an estimated $55.3K.
  • Merck made up 0.55% of M.E. Allison & Co's portfolio in Q3 2026, its #48 holding.
  • M.E. Allison & Co first reported a position in Merck in Q4 2024 and has held it in 8 quarters since.
  • 985 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on M.E. Allison & Co's 13F filing for Q3 2026, filed 9 Oct 2026.